Clinical Scorecard: What the Iran War Means for Pharma Supply Chains
At a Glance
| Category | Detail |
|---|---|
| Condition | Pharmaceutical Supply Chain Disruption |
| Key Mechanisms | Geopolitical instability affecting APIs, cold chain logistics, manufacturing costs, and access to critical medicines. |
| Target Population | Life sciences companies and patients relying on pharmaceuticals. |
| Care Setting | Pharmaceutical manufacturing and distribution. |
Key Highlights
- Only 22% of firms are preparing for supply chain disruptions.
- 62% of life sciences leaders report pressure to reduce operational costs.
- Medicines requiring refrigeration are particularly vulnerable to geopolitical instability.
- Energy market disruptions are impacting pharmaceutical manufacturing costs.
- Scenario planning is underused in the pharmaceutical industry.
Guideline-Based Recommendations
Diagnosis
- Identify vulnerabilities in supply chains related to geopolitical risks.
Management
- Implement dual sourcing and increased safety stock for critical medicines.
Monitoring & Follow-up
- Continuously assess geopolitical risks and their impact on supply chains.
Risks
- Potential for widespread medicine shortages and increased prices due to supply chain disruptions.
Patient & Prescribing Data
Patients dependent on essential medicines, particularly those requiring refrigeration.
Rising costs and potential shortages may affect access to medications.
Clinical Best Practices
- Adopt a strategic approach to supply chain design based on product criticality.
- Integrate scenario planning into everyday decision-making.
- Balance efficiency with resilience in supply chain management.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
